66 related articles for article (PubMed ID: 17203888)
1. New [1,2,4]triazolo[4,3-c]quinazoline enhances cisplatin- and temozolomide-induced growth inhibition and apoptosis in HL-60 cells.
Cipak L; Letasiova S; Repicky A; Jantova S
Neoplasma; 2007; 54(1):16-20. PubMed ID: 17203888
[TBL] [Abstract][Full Text] [Related]
2. The effect of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c]quinazoline on cell growth, cell cycle, induction of DNA fragmentation, and activity of caspase 3 in murine leukemia L1210 cells and fibroblast NIH-3T3 cells.
Jantová S; Letasiová S; Repický A; Ovádeková R; Lakatos B
Cell Biochem Funct; 2006; 24(6):519-30. PubMed ID: 16342136
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16.
Jantová S; Letasiová S; Ovádeková R; Múcková M
Neoplasma; 2006; 53(4):291-300. PubMed ID: 16830055
[TBL] [Abstract][Full Text] [Related]
4. Novel nonclassical antifolate, 2-[N-(2´-Hydroxyethyl)amino]methyl-3H-quinazolin-4-one, with a potent antineoplastic activity toward leukemia cells.
Cipak L
Neoplasma; 2012; 59(6):641-9. PubMed ID: 22862178
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition and apoptosis induced by 2-phenoxymethyl-3H-quinazolin-4-one in HL-60 leukemia cells.
Cipak L; Repicky A; Jantova S
Exp Oncol; 2007 Mar; 29(1):13-7. PubMed ID: 17431382
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
7. Distinct effects of novel naphtoquinone-based triazoles in human leukaemic cell lines.
Coulidiati TH; Dantas BB; Faheina-Martins GV; Gonçalves JC; do Nascimento WS; de Oliveira RN; Camara CA; Oliveira EJ; Lara A; Gomes ER; Araújo DA
J Pharm Pharmacol; 2015 Dec; 67(12):1682-95. PubMed ID: 26256440
[TBL] [Abstract][Full Text] [Related]
8. Natural antioxidants synergistically enhance the anticancer potential of AP9-cd, a novel lignan composition from Cedrus deodara in human leukemia HL-60 cells.
Saxena A; Saxena AK; Singh J; Bhushan S
Chem Biol Interact; 2010 Dec; 188(3):580-90. PubMed ID: 20932957
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human PLD2 on proliferation and apoptosis of HL-60 cells.
Zhu L; Wang YX; Yu CX
Cell Biol Int; 2008 Feb; 32(2):253-63. PubMed ID: 17977756
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and detection of damage to DNA by 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c] quinazoline on human cancer cell line HeLa.
Ovádeková R; Jantová S; Theiszová M; Labuda J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):455-9. PubMed ID: 16601809
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
[TBL] [Abstract][Full Text] [Related]
15. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.
Yi JL; Shi S; Shen YL; Wang L; Chen HY; Zhu J; Ding Y
Int J Clin Exp Pathol; 2015; 8(2):1116-27. PubMed ID: 25972998
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
17. Induction of G2/M phase arrest and apoptosis of human leukemia cells by potent antitumor triazoloacridinone C-1305.
Augustin E; Moś-Rompa A; Skwarska A; Witkowski JM; Konopa J
Biochem Pharmacol; 2006 Dec; 72(12):1668-79. PubMed ID: 16970926
[TBL] [Abstract][Full Text] [Related]
18. Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839).
Friedmann B; Caplin M; Hartley JA; Hochhauser D
Clin Cancer Res; 2004 Oct; 10(19):6476-86. PubMed ID: 15475435
[TBL] [Abstract][Full Text] [Related]
19. GP7 can induce apoptotic DNA fragmentation of human leukemia cells through caspase-3-dependent and -independent pathways.
Qi SN; Yoshida A; Wang ZR; Ueda T
Int J Mol Med; 2004 Jan; 13(1):163-7. PubMed ID: 14654989
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity and apoptosis induced by 6-bromo-2-(morpholin-1-yl)-4-anilinoquinazoline on cells of leukemia lines.
Jantova S; Repicky A; Paulovicova E; Letasiova S; Cipak L
Exp Oncol; 2008 Jun; 30(2):139-42. PubMed ID: 18566578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
